According to the report by Allied Market Research, titled, “Cancer Diagnostics Market by Product (Consumables and Instruments), Application (Breast Cancer, Breast Cancer, Lung Cancer, Blood Cancer, Colorectal Cancer, Skin Cancer, Ovarian Cancer, Prostate Cancer, Kidney Cancer, Liver Cancer, Pancreatic Cancer, Cervical Cancer, and Others), and End Use (Hospitals & Clinics, Diagnostic Laboratories, Diagnostic Centers, and Research Institutes): Opportunity Analysis and Industry Forecast, 2021–2028. The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.

The global cancer diagnostics market size was valued at $168,600.04 million in 2020, and is projected to reach $280,590.21 million by 2028, registering a CAGR of 6.9% from 2021 to 2028.

Increase in incidences and prevalence of various cancer types, initiatives by government and other organizations to spread awareness about cancer, and surge in number of diagnostics laboratories in developed countries drive the growth of the global cancer diagnostics market. However, risk of high radiation exposure by the use of CT scanners and high cost associated with diagnostics imaging systems hinder the market growth. On the contrary, development of diagnostic approaches for various cancer mutations is expected to create lucrative opportunities for the market players in the future.

Request The Free Sample PDF Of This Report:

https://www.alliedmarketresearch.com/request-sample/11701

Comprehensive competitive analysis and profiles of major market players, such as

  • Becton, Dickinson and Company
  • Abbott Laboratories
  • Roche Holdings AG (F. Hoffmann-La Roche Ltd.)
  • Bio-Rad Laboratories, Inc.
  • Hologic, Inc.
  • Danaher Corporation (GE Healthcare)
  • Qiagen N.V.
  • Koninklijke Philips N.V. (Philips Healthcare)
  • Thermo Fisher Scientific.
  • Siemens Healthcare GmbH.

Key Findings Of The Study 

  • By product, the consumables segment held the largest cancer diagnostics market share in 2020, and is expected to remain dominant during the forecast period.
  • On the basis of application, the breast cancer segment held the largest cancer diagnostics market share in 2020, and is expected to remain dominant during the forecast period.
  • On the basis of end use, the hospital & clinics segment held the largest market share in 2020, and is expected to remain dominant during the forecast period.

 

https://www.alliedmarketresearch.com/request-for-customization/11701

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with vario research data tables and confirms utmost accuracy in our market forecasting. Each and ever us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.